Adverse outcome pathway for mitochondrial complex 1 (C1) inhibition (WP4914)

Homo sapiens

Open in new tab
Download PNG Download SVG Download JSON Download GPML Learn more about Downloads
Adverse Outcome Pathway (AOP) network for mitochondrial Complex 1 (C1) inhibition leading to adverse outcomes in kidney, brain and liver. Adverse Outcome Pathways (AOPs), in general, are defined as a sequence of key events that begins with a molecular initiating event (MIE) and leads to an Adverse Outcome. At that level, AOPs are described in the [https://aopwiki.org/ AOPWiki]. This AOP network is based on 3 AOPs: [https://aopwiki.org/aops/3 AOPwiki:3], [https://aopwiki.org/aops/273 AOPwiki:273] and [https://aopwiki.org/aops/276 AOPwiki:276].

Authors

Anna Baya Meuleman , Egon Willighagen , Marvin Martens , Chris Evelo , and Eric Weitz

Activity

last edited

Discuss this pathway

Check for ongoing discussions or start your own.

Cited In

Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.

Organisms

Homo sapiens

Communities

Annotations

Pathway Ontology

immune response pathway altered energy metabolic pathway

Disease Ontology

Fanconi-like syndrome Parkinson's disease

Participants

Label Type Compact URI Comment
Deguelin Metabolite chebi:4357
Rotenone Metabolite chebi:28201

References